Cancer biomarker developer Abcodia has appointed Mike Fisher to be director of business development and Steve Pereira as a specialist advisor.
Fisher, who will lead the firm's commercial activities, formerly was business development director at Bio Nano Consulting and a senior advisor to the UK government and the North American UK Trade and Investment Network for the Life Science Industry.
Pereira, who will advise the company on developing biomarkers for early diagnosis and screening of pancreatic cancer, is a consultant gastroenterologist at several hospitals in London and is chairman of the British Society of Gastroenterology's Pancreatic Section.